Peptides DB
Research-centric peptide and protocol reference hub
Study 23 of 55Glutathione (GSH) literaturebiorxiv-preprint · Observational2026

Metabolic signatures of cone-dominant and cone-degenerating retinas

This study highlights significant metabolic changes in cone-dominant and degenerating retinas, particularly increases in glutathione and aminoadipate, which may indicate metabolic vulnerabilities in retinal health.

Read at biorxiv-preprintAdd to compare

Where it sits

this study against the rest of the glutathione (gsh) corpus
5
Preclinical
42
Observational · this one
0
Open-label
4
Randomised
4
Reviews

Summary and findings

This study investigated cone-specific metabolism in cone-dominant and cone-degenerating mouse models, including Nrl -/- and Cnga3 -/- models, with a focus on metabolic changes in the retinal pigment epithelium. The research found increases in glutathione and several amino acids, alongside decreases in pyruvate and uracil. The findings suggest potential metabolic vulnerabilities associated with cone degeneration.

How much of this paper we could read: full text read (0.70). We had a clear abstract, so the summary below closely tracks the paper. What this means →
Not reported in abstract.2026

Abstract

The authors’ words, as biorxiv-preprint supplied them

Cone photoreceptors are essential for daylight vision, and their degeneration has more profound visual consequences than rod loss in retinal degenerative diseases. Metabolic dysfunction is closely associated with cone degeneration, however the relatively small population of cones in mice and humans have limited our understanding of cone-specific metabolism. Here, we leveraged cone-dominant and cone-degeneration mouse models including Nrl -/- , Cnga3 -/- , and high-dose Triiodothyronine (T3) treatment to investigate cone-specific metabolism and their metabolic impacts on the retinal pigment epithelium (RPE). Across models, cone-dominant retinas consistently showed lower pyruvate abundance alongside increases in glutathione, purines, pentose phosphate pathway intermediates, and one-carbon metabolites. Increases in several key amino acids were also associated with higher cone abundance, such as proline, arginine, alanine, valine, leucine, and hypotaurine. Strikingly, aminoadipate, an intermediate in lysine catabolism, was the most robustly changed metabolite in the retina, showing highly consistent increases across models. Relative cone increases were also associated with metabolic changes in the RPE/choroid. Like the retina, RPE/choroids showed consistent increases in aminoadipate, proline, and hypotaurine, as well as xanthosine and betaine, alongside decreases in uracil. Moreover, proteomic analysis of Nrl -/- mice showed decreases in many key metabolite transporters in the RPE/choroid, including carriers for glucose, lactate, aspartate, glutamate, serine, lysine, taurine, and proline. Collectively, these findings further our understanding of cone-specific metabolism and highlight potential cone-specific metabolic vulnerabilities in retinal degeneration.

Elsewhere in the Glutathione (GSH) corpus

CAging Differentially Remodels the Retina and RPE/Choroid Proteome and Metabolismbiorxiv-preprint · 2026 · Not reported in abstract.AnimalCExtracellular GPX3 drives insulin receptor expression in adipose tissue independent of its peroxidase activitybiorxiv-preprint · 2026 · Not reported in abstract.AnimalCFragment-Shaped Microplastics Induce Size- and Polymer-Dependent Physiological and Gut Microbial Responses in Mytilus edulisbiorxiv-preprint · 2026 · Superoxide dismutase (SOD) peaked at 87.3 U/mg on day 7.AnimalCGlutathione Protects Hematopoietic Stem Cells from Proteotoxic Stressbiorxiv-preprint · 2026 · Not reported in abstract.AnimalCDietary Curcumin Improves Muscle Nutritional Quality and Hepatopancreatic Homeostasis in the Green–Pacific Abalone Hybrid (<em>Haliotis discus hannai</em> ♀ × <em>H. fulgens</em> ♂): Physiological and Transcriptomic Evidencebiorxiv-preprint · 2026 · n=240 · 0.04% curcumin increased muscle crude protein.AnimalCA Novel ACLY Inhibitor Induces Transcriptional and Metabolic Reprogramming to Overcome Tyrosine kinase inhibitor Resistance in Lymphomabiorxiv-preprint · 2023 · IC₅₀ of VCB1 against recombinant human ACLY was 0.9 uM.In vitro